SFG
IDXX icon

Sovereign Financial Group’s Idexx Laboratories IDXX Stock Holding History

Sovereign Financial Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$214K Sell
407
-6
-1% -$3.37K 0.03% 353
2026
Q1 		$232K Buy
413
+5
+1% +$3.21K 0.04% 316
2025
Q4 		$276K Buy
408
+9
+2% +$6.13K 0.05% 284
2025
Q3 		$255K Hold
399
– – 0.05% 284
2025
Q2 		$214K Buy
+399
New +$191K 0.04% 290
2024
Q4 		– Sell
-470
Closed -$237K – 290
2024
Q3 		$237K Buy
470
+23
+5% +$11.2K 0.06% 253
2024
Q2 		$218K Buy
447
+5
+1% +$2.51K 0.05% 256
2024
Q1 		$239K Buy
442
+8
+2% +$4.37K 0.06% 248
2023
Q4 		$241K Buy
+434
New +$204K 0.07% 214
2023
Q3 		– Sell
-807
Closed -$405K – 242
2023
Q2 		$405K Hold
807
– – 0.13% 157
2023
Q1 		$404K Sell
807
-1
-0.1% -$479 0.15% 143
2022
Q4 		$330K Buy
808
+11
+1% +$4.27K 0.13% 159
2022
Q3 		$260K Sell
797
-23
-3% -$8.45K 0.11% 170
2022
Q2 		$288K Buy
820
+15
+2% +$6.12K 0.11% 162
2022
Q1 		$440K Buy
805
+401
+99% +$211K 0.16% 133
2021
Q4 		$266K Sell
404
-2
-0.5% -$1.26K 0.11% 170
2021
Q3 		$252K Buy
+406
New +$273K 0.14% 136
2021
Q1 		– Sell
-403
Closed -$201K – 168
2020
Q4 		$201K Buy
+403
New +$180K 0.14% 132

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Sovereign Financial Group's IDXX Position: Q2 2026 in Review

Sovereign Financial Group reduced its Idexx Laboratories (IDXX) stake by 1.5% in Q2 2026, selling an estimated $3.37K and leaving 407 shares worth $214K. The position accounts for 0.03% of the portfolio, ranked #353.

Sovereign Financial Group first reported a position in IDXX in Q4 2020 and has held it in 18 quarters since. The position peaked at $440K in Q1 2022. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Sovereign Financial Group held 407 shares of Idexx Laboratories worth $214K as of Q2 2026.
  • Sovereign Financial Group sold 6 Idexx Laboratories shares in Q2 2026, an estimated $3.37K.
  • Idexx Laboratories made up 0.03% of Sovereign Financial Group's portfolio in Q2 2026, its #353 holding.
  • Sovereign Financial Group first reported a position in Idexx Laboratories in Q4 2020 and has held it in 18 quarters since.
  • Sovereign Financial Group's Idexx Laboratories position peaked at $440K in Q1 2022.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Sovereign Financial Group's 13F filing for Q2 2026, filed 24 Jul 2026.